Baseline Analysis of a Young α-1-Antitrypsin Deficiency Liver Disease Cohort Reveals Frequent Portal Hypertension

Jeffrey H. Teckman, Philip Rosenthal, Robert Abel, Lee M. Bass, Sonia Michail, Karen F. Murray, David A. Rudnick, Daniel W. Thomas, Cathie Spino, Ronen Arnon, Paula M. Hertel, James Heubi, Binita M. Kamath, Wikrom Karnsakul, Kathleen M. Loomes, John C. Magee, Jean Molleston, Rene Romero, Benjamin L. Shneider, Averell H. SherkerRonald J. Sokol

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objectives: α-1-Antitrypsin (A1AT) deficiency is a common genetic disease with an unpredictable and highly variable course. The Childhood Liver Disease Research and Education Network is a National Institutes of Health, multicenter, longitudinal consortium studying pediatric liver diseases, with the objective of prospectively defining natural history and identifying disease modifiers. Methods: Longitudinal, cohort study of A1AT patients' birth through 25 years diagnosed as having liver disease, type PIZZ or PISZ. Medical history, physical examination, laboratory, imaging, and standardized survey tool data were collected during the provision of standard of care. Results: In the present report of the cohort at baseline, 269 subjects were enrolled between November 2008 and October 2012 (208 with their native livers and 61 postliver transplant). Subjects with mild disease (native livers and no portal hypertension [PHT]) compared to severe disease (with PHT or postliver transplant) were not different in age at presentation. A total of 57% of subjects with mild disease and 76% with severe disease were jaundiced at presentation (P = 0.0024). A total of 29% of subjects with native livers had PHT, but age at diagnosis and growth were not different between the no-PHT and PHT groups (P > 0.05). Subjects with native livers and PHT were more likely to have elevated bilirubin, ALT, AST, INR, and GGTP than the no-PHT group (P

Original languageEnglish (US)
Pages (from-to)94-101
Number of pages8
JournalJournal of Pediatric Gastroenterology and Nutrition
Volume61
Issue number1
DOIs
StatePublished - Jul 23 2015

Fingerprint

Deficiency Diseases
Portal Hypertension
Liver Diseases
Liver
Transplants
Inborn Genetic Diseases
International Normalized Ratio
gamma-Glutamyltransferase
National Institutes of Health (U.S.)
Standard of Care
Jaundice
Natural History
Bilirubin
Physical Examination
Longitudinal Studies
Cohort Studies
Parturition
Pediatrics
Education
Growth

Keywords

  • cirrhosis
  • jaundice
  • liver enzymes
  • liver transplant
  • metabolic liver disease

ASJC Scopus subject areas

  • Gastroenterology
  • Pediatrics, Perinatology, and Child Health

Cite this

Baseline Analysis of a Young α-1-Antitrypsin Deficiency Liver Disease Cohort Reveals Frequent Portal Hypertension. / Teckman, Jeffrey H.; Rosenthal, Philip; Abel, Robert; Bass, Lee M.; Michail, Sonia; Murray, Karen F.; Rudnick, David A.; Thomas, Daniel W.; Spino, Cathie; Arnon, Ronen; Hertel, Paula M.; Heubi, James; Kamath, Binita M.; Karnsakul, Wikrom; Loomes, Kathleen M.; Magee, John C.; Molleston, Jean; Romero, Rene; Shneider, Benjamin L.; Sherker, Averell H.; Sokol, Ronald J.

In: Journal of Pediatric Gastroenterology and Nutrition, Vol. 61, No. 1, 23.07.2015, p. 94-101.

Research output: Contribution to journalArticle

Teckman, JH, Rosenthal, P, Abel, R, Bass, LM, Michail, S, Murray, KF, Rudnick, DA, Thomas, DW, Spino, C, Arnon, R, Hertel, PM, Heubi, J, Kamath, BM, Karnsakul, W, Loomes, KM, Magee, JC, Molleston, J, Romero, R, Shneider, BL, Sherker, AH & Sokol, RJ 2015, 'Baseline Analysis of a Young α-1-Antitrypsin Deficiency Liver Disease Cohort Reveals Frequent Portal Hypertension', Journal of Pediatric Gastroenterology and Nutrition, vol. 61, no. 1, pp. 94-101. https://doi.org/10.1097/MPG.0000000000000753
Teckman, Jeffrey H. ; Rosenthal, Philip ; Abel, Robert ; Bass, Lee M. ; Michail, Sonia ; Murray, Karen F. ; Rudnick, David A. ; Thomas, Daniel W. ; Spino, Cathie ; Arnon, Ronen ; Hertel, Paula M. ; Heubi, James ; Kamath, Binita M. ; Karnsakul, Wikrom ; Loomes, Kathleen M. ; Magee, John C. ; Molleston, Jean ; Romero, Rene ; Shneider, Benjamin L. ; Sherker, Averell H. ; Sokol, Ronald J. / Baseline Analysis of a Young α-1-Antitrypsin Deficiency Liver Disease Cohort Reveals Frequent Portal Hypertension. In: Journal of Pediatric Gastroenterology and Nutrition. 2015 ; Vol. 61, No. 1. pp. 94-101.
@article{2605c85ae47a4ee68d7cb329c880fe3a,
title = "Baseline Analysis of a Young α-1-Antitrypsin Deficiency Liver Disease Cohort Reveals Frequent Portal Hypertension",
abstract = "Objectives: α-1-Antitrypsin (A1AT) deficiency is a common genetic disease with an unpredictable and highly variable course. The Childhood Liver Disease Research and Education Network is a National Institutes of Health, multicenter, longitudinal consortium studying pediatric liver diseases, with the objective of prospectively defining natural history and identifying disease modifiers. Methods: Longitudinal, cohort study of A1AT patients' birth through 25 years diagnosed as having liver disease, type PIZZ or PISZ. Medical history, physical examination, laboratory, imaging, and standardized survey tool data were collected during the provision of standard of care. Results: In the present report of the cohort at baseline, 269 subjects were enrolled between November 2008 and October 2012 (208 with their native livers and 61 postliver transplant). Subjects with mild disease (native livers and no portal hypertension [PHT]) compared to severe disease (with PHT or postliver transplant) were not different in age at presentation. A total of 57{\%} of subjects with mild disease and 76{\%} with severe disease were jaundiced at presentation (P = 0.0024). A total of 29{\%} of subjects with native livers had PHT, but age at diagnosis and growth were not different between the no-PHT and PHT groups (P > 0.05). Subjects with native livers and PHT were more likely to have elevated bilirubin, ALT, AST, INR, and GGTP than the no-PHT group (P",
keywords = "cirrhosis, jaundice, liver enzymes, liver transplant, metabolic liver disease",
author = "Teckman, {Jeffrey H.} and Philip Rosenthal and Robert Abel and Bass, {Lee M.} and Sonia Michail and Murray, {Karen F.} and Rudnick, {David A.} and Thomas, {Daniel W.} and Cathie Spino and Ronen Arnon and Hertel, {Paula M.} and James Heubi and Kamath, {Binita M.} and Wikrom Karnsakul and Loomes, {Kathleen M.} and Magee, {John C.} and Jean Molleston and Rene Romero and Shneider, {Benjamin L.} and Sherker, {Averell H.} and Sokol, {Ronald J.}",
year = "2015",
month = "7",
day = "23",
doi = "10.1097/MPG.0000000000000753",
language = "English (US)",
volume = "61",
pages = "94--101",
journal = "Journal of Pediatric Gastroenterology and Nutrition",
issn = "0277-2116",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Baseline Analysis of a Young α-1-Antitrypsin Deficiency Liver Disease Cohort Reveals Frequent Portal Hypertension

AU - Teckman, Jeffrey H.

AU - Rosenthal, Philip

AU - Abel, Robert

AU - Bass, Lee M.

AU - Michail, Sonia

AU - Murray, Karen F.

AU - Rudnick, David A.

AU - Thomas, Daniel W.

AU - Spino, Cathie

AU - Arnon, Ronen

AU - Hertel, Paula M.

AU - Heubi, James

AU - Kamath, Binita M.

AU - Karnsakul, Wikrom

AU - Loomes, Kathleen M.

AU - Magee, John C.

AU - Molleston, Jean

AU - Romero, Rene

AU - Shneider, Benjamin L.

AU - Sherker, Averell H.

AU - Sokol, Ronald J.

PY - 2015/7/23

Y1 - 2015/7/23

N2 - Objectives: α-1-Antitrypsin (A1AT) deficiency is a common genetic disease with an unpredictable and highly variable course. The Childhood Liver Disease Research and Education Network is a National Institutes of Health, multicenter, longitudinal consortium studying pediatric liver diseases, with the objective of prospectively defining natural history and identifying disease modifiers. Methods: Longitudinal, cohort study of A1AT patients' birth through 25 years diagnosed as having liver disease, type PIZZ or PISZ. Medical history, physical examination, laboratory, imaging, and standardized survey tool data were collected during the provision of standard of care. Results: In the present report of the cohort at baseline, 269 subjects were enrolled between November 2008 and October 2012 (208 with their native livers and 61 postliver transplant). Subjects with mild disease (native livers and no portal hypertension [PHT]) compared to severe disease (with PHT or postliver transplant) were not different in age at presentation. A total of 57% of subjects with mild disease and 76% with severe disease were jaundiced at presentation (P = 0.0024). A total of 29% of subjects with native livers had PHT, but age at diagnosis and growth were not different between the no-PHT and PHT groups (P > 0.05). Subjects with native livers and PHT were more likely to have elevated bilirubin, ALT, AST, INR, and GGTP than the no-PHT group (P

AB - Objectives: α-1-Antitrypsin (A1AT) deficiency is a common genetic disease with an unpredictable and highly variable course. The Childhood Liver Disease Research and Education Network is a National Institutes of Health, multicenter, longitudinal consortium studying pediatric liver diseases, with the objective of prospectively defining natural history and identifying disease modifiers. Methods: Longitudinal, cohort study of A1AT patients' birth through 25 years diagnosed as having liver disease, type PIZZ or PISZ. Medical history, physical examination, laboratory, imaging, and standardized survey tool data were collected during the provision of standard of care. Results: In the present report of the cohort at baseline, 269 subjects were enrolled between November 2008 and October 2012 (208 with their native livers and 61 postliver transplant). Subjects with mild disease (native livers and no portal hypertension [PHT]) compared to severe disease (with PHT or postliver transplant) were not different in age at presentation. A total of 57% of subjects with mild disease and 76% with severe disease were jaundiced at presentation (P = 0.0024). A total of 29% of subjects with native livers had PHT, but age at diagnosis and growth were not different between the no-PHT and PHT groups (P > 0.05). Subjects with native livers and PHT were more likely to have elevated bilirubin, ALT, AST, INR, and GGTP than the no-PHT group (P

KW - cirrhosis

KW - jaundice

KW - liver enzymes

KW - liver transplant

KW - metabolic liver disease

UR - http://www.scopus.com/inward/record.url?scp=84937729261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937729261&partnerID=8YFLogxK

U2 - 10.1097/MPG.0000000000000753

DO - 10.1097/MPG.0000000000000753

M3 - Article

C2 - 25651489

AN - SCOPUS:84937729261

VL - 61

SP - 94

EP - 101

JO - Journal of Pediatric Gastroenterology and Nutrition

JF - Journal of Pediatric Gastroenterology and Nutrition

SN - 0277-2116

IS - 1

ER -